Healthcare Sales & Marketing Network News: Celsentri

Searching News Database: Celsentri

HSMN NewsFeed - 8 Oct 2009
FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting HIV Therapy for the First Time
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 16 Apr 2009
GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 6 Feb 2008
Pfizer Presents New Data from HIV/AIDS Portfolio at Conference on Retroviruses and Opportunistic Infections
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 15 Nov 2007
Significant Changes in Store for Growing HIV Market
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 24 Sep 2007
Pfizer's Celsentri(R) Approved in the European Union, Providing a Novel Treatment Option for Treatment-Experienced HIV Patients
Biopharmaceuticals HIV/AIDS Regulatory

HSMN NewsFeed - 18 Sep 2007
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 6 Aug 2007
Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 20 Jul 2007
European Committee Issues Positive Opinion of Pfizer's Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1
Biopharmaceuticals HIV/AIDS

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.